247 related articles for article (PubMed ID: 15859637)
1. Immunohistochemical detection of glucose transporter GLUT1 in benign and malignant fallopian tube epithelia, with comparison to ovarian carcinomas.
Kalir T; Rahaman J; Hagopian G; Demopoulos R; Cohen C; Burstein DE
Arch Pathol Lab Med; 2005 May; 129(5):651-4. PubMed ID: 15859637
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia.
Kalir T; Wang BY; Goldfischer M; Haber RS; Reder I; Demopoulos R; Cohen CJ; Burstein DE
Cancer; 2002 Feb; 94(4):1078-82. PubMed ID: 11920478
[TBL] [Abstract][Full Text] [Related]
3. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
Wen J; Shi JL; Shen DH; Chen YX; Song QJ
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE
Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060
[TBL] [Abstract][Full Text] [Related]
5. Endosalpingiosis as it relates to tubal, ovarian and serous neoplastic tissues: an immunohistochemical study of tubal and Müllerian antigens.
Esselen KM; Ng SK; Hua Y; White M; Jimenez CA; Welch WR; Drapkin R; Berkowitz RS; Ng SW
Gynecol Oncol; 2014 Feb; 132(2):316-21. PubMed ID: 24333360
[TBL] [Abstract][Full Text] [Related]
6. Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases.
Maeda D; Ota S; Takazawa Y; Ohashi K; Mori M; Imamura T; Nakagawa S; Yano T; Taketani Y; Fukayama M
Virchows Arch; 2010 Nov; 457(5):597-608. PubMed ID: 20872013
[TBL] [Abstract][Full Text] [Related]
7. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
8. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.
Kurman RJ; Vang R; Junge J; Hannibal CG; Kjaer SK; Shih IeM
Am J Surg Pathol; 2011 Nov; 35(11):1605-14. PubMed ID: 21997682
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
10. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a Novel Endometrioid Carcinogenic Sequence in the Fallopian Tube With Unique Beta-Catenin Expression.
Brouwer J; Strickland KC; Ning G; Schmelkin CB; Kolin DL; Hecht J; Nucci MR; Mourits MJ; Xian W; Crum CP
Int J Gynecol Pathol; 2020 Mar; 39(2):163-169. PubMed ID: 31574529
[TBL] [Abstract][Full Text] [Related]
12. Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia.
Rabban JT; Vohra P; Zaloudek CJ
Am J Surg Pathol; 2015 Jan; 39(1):35-51. PubMed ID: 25025442
[TBL] [Abstract][Full Text] [Related]
13. Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma.
Chui MH; Vang R; Wang TL; Shih IM; VandenBussche CJ
Cancer Cytopathol; 2019 Mar; 127(3):192-201. PubMed ID: 30861338
[TBL] [Abstract][Full Text] [Related]
14. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
Soong TR; Howitt BE; Miron A; Horowitz NS; Campbell F; Feltmate CM; Muto MG; Berkowitz RS; Nucci MR; Xian W; Crum CP
J Pathol; 2018 Nov; 246(3):344-351. PubMed ID: 30043522
[TBL] [Abstract][Full Text] [Related]
15. Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.
Press JZ; Wurz K; Norquist BM; Lee MK; Pennil C; Garcia R; Welcsh P; Goff BA; Swisher EM
Neoplasia; 2010 Dec; 12(12):993-1002. PubMed ID: 21170264
[TBL] [Abstract][Full Text] [Related]
16. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
17. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations.
Rabban JT; Crawford B; Chen LM; Powell CB; Zaloudek CJ
Am J Surg Pathol; 2009 Jan; 33(1):111-9. PubMed ID: 18830124
[TBL] [Abstract][Full Text] [Related]
18. Lineage tracing suggests that ovarian endosalpingiosis does not result from escape of oviductal epithelium.
Wang Y; Sessine MS; Zhai Y; Tipton C; McCool K; Kuick R; Connolly DC; Fearon ER; Cho KR
J Pathol; 2019 Oct; 249(2):206-214. PubMed ID: 31131879
[TBL] [Abstract][Full Text] [Related]
19. [Morphological features of the fimbria of the fallopian tube in pelvic serous adenocarcinoma].
Guo DH; Pang SJ; Shen Y; Li Y
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):287-90. PubMed ID: 21575501
[TBL] [Abstract][Full Text] [Related]
20. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
